FDA
approval
· 2025-11-06
FDA Approved: VOQUEZNA — Supplemental Application (Phathom Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals, expanding its labeling for Helicobacter pylori infe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOQUEZNA (VONOPRAZAN FUMARATE)